![](/img/cover-not-exists.png)
Preclinical Development of a Neutral, Estrogen Receptor-Targeted, Tridentate 99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers
Nayak, T. K., Hathaway, H. J., Ramesh, C., Arterburn, J. B., Dai, D., Sklar, L. A., Norenberg, J. P., Prossnitz, E. R.Volume:
49
Language:
english
Journal:
Journal of Nuclear Medicine
DOI:
10.2967/jnumed.107.048546
Date:
May, 2008
File:
PDF, 691 KB
english, 2008